Investor Relations

Company Overview

Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis' proven technology drives improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics.